ORC6 and Mungan syndrome: Regardless, MGS patient-derived cells with ORC6 mutations can still proliferate efficiently in culture, although S-phase progression is slowed (Stiff et al, 2013), and most mutations in ORC6 are associated with a milder MGS phenotype (Nielsen-Dandoroff et al, 2023).